HC Wainwright & Co. : The Blueprint Medicines (BPMC.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $125.00 to $135.00.
Zhitong FinanceMay 4 04:20
Blueprint Medicines Analyst Ratings
BenzingaMay 4 03:00
JMP Securities Maintains Market Outperform on Blueprint Medicines, Raises Price Target to $125
BenzingaMay 4 03:02
Wells Fargo Remains a Buy on Blueprint Medicines (BPMC)
TipRanksMay 3 19:06
Sell/High Risk: Cautious Outlook on Blueprint Medicines Amidst Unsustainable Growth Factors
TipRanksMay 3 18:47
Ayvakit's Sales Surge Supports Buy Rating and Increased Price Target for Blueprint Medicines
TipRanksMay 3 18:27
Blueprint Medicines Analyst Ratings
BenzingaMay 3 17:49
Buy Rating Affirmed for Blueprint Medicines on Strong Financials and Clinical Pipeline Prospects
TipRanksMay 3 12:25
Wedbush Raises Blueprint Medicines' Price Target to $120 From $110 After Stronger-Than-Expected Q1 Results, Keeps Outperform Rating
MT NewswiresMay 2 22:56
Blueprint Medicines Analyst Ratings
BenzingaMay 2 19:53
Needham Reiterates Buy on Blueprint Medicines, Maintains $97 Price Target
BenzingaMay 2 19:54
Analysts' Opinions Are Mixed on These Healthcare Stocks: 10x Genomics (TXG), Zoetis (ZTS) and Blueprint Medicines (BPMC)
TipRanksMay 1 15:41
Analysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK), Praxis Precision Medicines (PRAX) and Blueprint Medicines (BPMC)
TipRanksApr 26 18:20
Blueprint Medicines Analyst Ratings
BenzingaApr 26 17:33
Barclays Sticks to Its Hold Rating for Blueprint Medicines (BPMC)
TipRanksApr 26 16:47
Blueprint Medicines: Buy Rating Affirmed on BLU-808 Prospects and Strong Ayvakit Sales Forecast
TipRanksApr 26 08:05
Blueprint Medicines Analyst Ratings
BenzingaApr 10 22:58
Blueprint Medicines Buy Rating: Promising BLU-222 Efficacy and Strong Financial Outlook
TipRanksApr 10 04:25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bausch Health Companies (BHC), Blueprint Medicines (BPMC) and Evolent Health (EVH)
TipRanksApr 5 18:40
Blueprint Medicines Analyst Ratings
BenzingaFeb 26 19:51
No Data
No Data